The CHMP renders a positive opinion recommending approval for MRK's Keytruda for the first-line treatment of malignant ...

Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer: Princeton, New Jersey Monday, November 18, 2 ...

The CHMP's opinion is based on late-stage study data, which show that treatment with JNJ's combo drug reduces the risk of ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ... Stage III EGFRm NSCLC in the US. Regulatory applications are also currently under review in China, ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA ... Stage III EGFRm NSCLC in ...

"Retinal disorders are affecting millions of people's lives in Europe, yet many patients face barriers to treatment due to high costs," said Byoungin Jung, Vice President, Regulatory Affairs at ...

If approved by the EC, Tagrisso will be the first targeted therapy for European patients with unresectable EGFR-mutated cancer.